Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 3655355
[patent_doc_number] => 05622836
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'Monoclonal antibodies which recognize malignant cells from bladder carcinomas'
[patent_app_type] => 1
[patent_app_number] => 8/261009
[patent_app_country] => US
[patent_app_date] => 1994-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 30
[patent_no_of_words] => 14883
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/622/05622836.pdf
[firstpage_image] =>[orig_patent_app_number] => 261009
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/261009 | Monoclonal antibodies which recognize malignant cells from bladder carcinomas | Jun 13, 1994 | Issued |
Array
(
[id] => 3682789
[patent_doc_number] => 05695757
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-09
[patent_title] => 'Methods for treating post-exposure rabies and anti-rabies compositions'
[patent_app_type] => 1
[patent_app_number] => 8/255557
[patent_app_country] => US
[patent_app_date] => 1994-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4157
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/695/05695757.pdf
[firstpage_image] =>[orig_patent_app_number] => 255557
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/255557 | Methods for treating post-exposure rabies and anti-rabies compositions | Jun 7, 1994 | Issued |
Array
(
[id] => 3662761
[patent_doc_number] => 05599539
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-04
[patent_title] => 'Therapy for clostridial botulinum toxin'
[patent_app_type] => 1
[patent_app_number] => 8/255009
[patent_app_country] => US
[patent_app_date] => 1994-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10944
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/599/05599539.pdf
[firstpage_image] =>[orig_patent_app_number] => 255009
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/255009 | Therapy for clostridial botulinum toxin | Jun 6, 1994 | Issued |
Array
(
[id] => 3993347
[patent_doc_number] => 05858358
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Methods for selectively stimulating proliferation of T cells'
[patent_app_type] => 1
[patent_app_number] => 8/253751
[patent_app_country] => US
[patent_app_date] => 1994-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 48
[patent_no_of_words] => 19064
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858358.pdf
[firstpage_image] =>[orig_patent_app_number] => 253751
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/253751 | Methods for selectively stimulating proliferation of T cells | Jun 2, 1994 | Issued |
Array
(
[id] => 3689351
[patent_doc_number] => 05679345
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-21
[patent_title] => 'Method for preventing complement-dependent rejection of organ or tissue transplants'
[patent_app_type] => 1
[patent_app_number] => 8/253279
[patent_app_country] => US
[patent_app_date] => 1994-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12982
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/679/05679345.pdf
[firstpage_image] =>[orig_patent_app_number] => 253279
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/253279 | Method for preventing complement-dependent rejection of organ or tissue transplants | Jun 1, 1994 | Issued |
Array
(
[id] => 3845081
[patent_doc_number] => 05708145
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-13
[patent_title] => 'Immunglobulins reactive with protegrins'
[patent_app_type] => 1
[patent_app_number] => 8/243879
[patent_app_country] => US
[patent_app_date] => 1994-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 13014
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/708/05708145.pdf
[firstpage_image] =>[orig_patent_app_number] => 243879
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/243879 | Immunglobulins reactive with protegrins | May 16, 1994 | Issued |
08/243709 | METHOD FOR THE PREPARATION OF FREE RADICAL PHARMACEUTICALS, DIAGNOSTICS AND DEVICES USING SELENIUM CONJUGATES | May 16, 1994 | Abandoned |
Array
(
[id] => 3969059
[patent_doc_number] => 05886152
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-23
[patent_title] => 'Humanized B-B10'
[patent_app_type] => 1
[patent_app_number] => 8/232081
[patent_app_country] => US
[patent_app_date] => 1994-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 10792
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/886/05886152.pdf
[firstpage_image] =>[orig_patent_app_number] => 232081
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/232081 | Humanized B-B10 | May 9, 1994 | Issued |
Array
(
[id] => 3737979
[patent_doc_number] => 05698680
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'Antibodies specific for lipopolysaccharide binding protein'
[patent_app_type] => 1
[patent_app_number] => 8/240328
[patent_app_country] => US
[patent_app_date] => 1994-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 32
[patent_no_of_words] => 22579
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698680.pdf
[firstpage_image] =>[orig_patent_app_number] => 240328
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/240328 | Antibodies specific for lipopolysaccharide binding protein | May 9, 1994 | Issued |
08/235395 | BIFUNCTIONAL GLYCOPROTEINS HAVING A MODIFIED CARBOHYDRATE COMPLEMENT, AND THEIR USE IN TUMOR-SELECTIVE THERAPY | Apr 28, 1994 | Abandoned |
Array
(
[id] => 3888593
[patent_doc_number] => 05714585
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-03
[patent_title] => 'Antibodies that are immunoreactive with interleukin-7'
[patent_app_type] => 1
[patent_app_number] => 8/231205
[patent_app_country] => US
[patent_app_date] => 1994-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 17703
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/714/05714585.pdf
[firstpage_image] =>[orig_patent_app_number] => 231205
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/231205 | Antibodies that are immunoreactive with interleukin-7 | Apr 20, 1994 | Issued |
Array
(
[id] => 3604229
[patent_doc_number] => 05589174
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-31
[patent_title] => 'Anti-human influenza virus antibody'
[patent_app_type] => 1
[patent_app_number] => 8/229781
[patent_app_country] => US
[patent_app_date] => 1994-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28457
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/589/05589174.pdf
[firstpage_image] =>[orig_patent_app_number] => 229781
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/229781 | Anti-human influenza virus antibody | Apr 18, 1994 | Issued |
08/227963 | METHOD FOR INHIBITING DISEASE ASSOCIATED WITH THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH THE USE OF MONOCLONAL ANTIBODIES DIRECTED AGAINST ANTI-SELF CYTOTOXIC T-LYMPHOCYTES OR THEIR LYTICS | Apr 14, 1994 | Abandoned |
Array
(
[id] => 3775617
[patent_doc_number] => 05808032
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Anti-HBS antibody genes and expression plasmids therefor'
[patent_app_type] => 1
[patent_app_number] => 8/157101
[patent_app_country] => US
[patent_app_date] => 1994-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 6800
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/808/05808032.pdf
[firstpage_image] =>[orig_patent_app_number] => 157101
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/157101 | Anti-HBS antibody genes and expression plasmids therefor | Apr 4, 1994 | Issued |
Array
(
[id] => 3647322
[patent_doc_number] => 05639656
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-17
[patent_title] => 'Antibodies reactive with biological markers of benign prostate hyperplasia'
[patent_app_type] => 1
[patent_app_number] => 8/221821
[patent_app_country] => US
[patent_app_date] => 1994-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26429
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/639/05639656.pdf
[firstpage_image] =>[orig_patent_app_number] => 221821
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/221821 | Antibodies reactive with biological markers of benign prostate hyperplasia | Mar 30, 1994 | Issued |
08/220395 | PANCREAS ELASTASE 1-SPECIFIC ANTIBODY, A PROCESS FOR OBTAINING IT, ANDA TEST KIT CONTAINING SUCH ANTIBODY | Mar 29, 1994 | Abandoned |
Array
(
[id] => 3730477
[patent_doc_number] => 05665595
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-09
[patent_title] => 'Immunoglobulins against insect tissue'
[patent_app_type] => 1
[patent_app_number] => 8/216119
[patent_app_country] => US
[patent_app_date] => 1994-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9861
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/665/05665595.pdf
[firstpage_image] =>[orig_patent_app_number] => 216119
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/216119 | Immunoglobulins against insect tissue | Mar 17, 1994 | Issued |
08/210639 | NEW FACTOR VIII COAGULANT POLYPEPTIDES AND MONOCLONAL ANTIBODIES TO THEM | Mar 17, 1994 | Abandoned |
08/214347 | STABILIZATION OF PEPTIDES AND PROTEINS FOR RADIOPHARMACEUTICAL USE | Mar 15, 1994 | Abandoned |
Array
(
[id] => 3663928
[patent_doc_number] => 05597710
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-28
[patent_title] => 'Humanized monoclonal antibodies against human interleukin-4'
[patent_app_type] => 1
[patent_app_number] => 8/208886
[patent_app_country] => US
[patent_app_date] => 1994-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19341
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/597/05597710.pdf
[firstpage_image] =>[orig_patent_app_number] => 208886
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/208886 | Humanized monoclonal antibodies against human interleukin-4 | Mar 9, 1994 | Issued |